Identification of cancer/testis-antigen genes by massively parallel signature sequencing
โ Scribed by Chen, Y.-T.; Scanlan, M. J.; Venditti, C. A.; Chua, R.; Theiler, G.; Stevenson, B. J.; Iseli, C.; Gure, A. O.; Vasicek, T.; Strausberg, R. L.
- Book ID
- 111644886
- Publisher
- National Academy of Sciences
- Year
- 2005
- Tongue
- English
- Weight
- 388 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0027-8424
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Cancer/testis (CT) antigens are immunogenic proteins expressed predominantly in gametogenic tissue and cancer; they are considered promising target molecules for cancer vaccines. The identification of new CT genes is essential to the development of polyvalent cancer vaccines designed to
This study describes how the new massive parallel sequencing technology can be implemented in a diagnostic setting for the breast cancer susceptibility genes (BRCA1 and BRCA2). The throughput was maximized by increasing uniformity in coverage, obtained by a multiplex approach, which outperformed poo